Portal de Oportunidades de Pesquisa – POP – Propesq

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

Inscrições:
R21/R33: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.

Inscrições:
R01: October 05, 2017;
R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações em R01 e R21.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações no site.

Objetivo:
The Funding Opportunity Announcement (FOA) invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system (CNS) in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
January 8, 2020.

Mais informações no site.

Objetivo:
Apresentar novas ideias e contribuições sobre os temas propostos, que propiciem o aperfeiçoamento do planejamento governamental, o aprimoramento das políticas públicas e ampliem o debate sobre as reformas econômicas para maior eficácia e efetividade das políticas e programas governamentais, além da melhoria do ambiente de negócios no Brasil.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.

Objetivo:
The Barth Syndrome Foundation (BSF) is the only worldwide volunteer organization dedicated to saving lives through education, advances in treatment, and finding a cure for Barth syndrome (BTHS). The Foundation strives to accelerate progress through collaboration between families and scientists. Also, it provides several ways to keep up-to-date about advances in science and medicine.

Inscrições:
até dia 31 de outubro de 2017.

Mais informações no site.

Objetivo:
The purpose of the Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD).

Inscrições:
R01: October 05, 2017;
R03 and R21: October 16, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
September 8, 2019.

Mais informações em R01, R03 e R21.

Objetivo:
Founded by parents of children with type 1 juvenile diabetes, the Juvenile Diabetes Research Foundation International (JDRF) has always focused on a single goal – accelerating research progress to cure diabetes and its complications. The Industry Discovery and Development Partnerships (IDDP) are intended to provide support to companies/for-profit entities for research programs that are closely focused on a priority area within JDRF’s mission.

Inscrições:
Letters of Intent and Applications are reviewed on an ongoing basis in order to accelerate the time between initial application and potential funding.

Mais informações no site.

Objetivo:
The Society for Integrative and Comparative Biology (SICB) is one of the largest and most prestigious professional associations of its kind. Formed as the American Society of Zoologists through a 1902 merger of two societies, the Central Naturalists and the American Morphological Society, its focus has remained to integrate the many fields of specialization which occur in the broad field of biology. The mission of SICB is to further research, education and public awareness in the areas of organismal, functional and evolutionary biology.

Inscrições:
até dia 20 de outubro de 2017.

Mais informações no site.

Objetivo:
Data from clinical studies of metformin in a variety of patient populations suggest that it may have other effects, besides being an antihyperglycemic agent, which warrant further attention in translational aging research. The objective of the Funding Opportunity Announcement (FOA) is to support research projects (R01), including small-scale physiologic studies in humans or secondary analyses of data and/or stored biospecimens from controlled clinical intervention studies, to increase the understanding of the clinical translational potential of metformin to delay deleterious aging changes or to extend healthy human life span. This includes identification of specific populations particularly likely to benefit from treatment, and/or obtaining information on metformins human physiologic and cellular effects that would be useful in identifying novel molecular targets.

Inscrições:
R01: October 05, 2017.

Letter of Intent Due Date(s):
30 days prior to the application due date.

Data de expiração:
May 8, 2020.

Mais informações no site.